TrueTear in Sjogren's Disease Patients

TrueTear in Sjogren's Disease Patients

The purpose of this study is to evaluate acute tear production produced by the intranasal tear neurostimulator in participants with SjA?grens syndrome and aqueous tear deficiency. Our primary goal is to evaluate whether SjA?grens patients respond to this intervention and whether there is a baseline tear production level below which these patients do not respond.

No pharmaceutical medication involved
Patients and healthy individuals accepted

Device - TrueTear Intranasal Tear Neurostimulator

This study will evaluate the immediate tear production resulting from use of intranasal tear neurostimulation in patients with Sjogren's disease

Prospective Controlled Study of Intranasal Tear Neurostimulation for Sjogrens Patients With Dry Eye Disease